These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 12171902)

  • 21. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.
    Liu X; Dai X; Wu B
    Urol Int; 2009; 82(1):108-12. PubMed ID: 19172108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-testis antigen expression in bladder cancer.
    Fradet Y; Picard V; Bergeron A; LaRue H
    Prog Urol; 2005 Dec; 15(6 Suppl 1):1303-13. PubMed ID: 16734221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlorin e6-mediated photodynamic effect diminishes therapeutic potential of 5-aza-2'-deoxycytidine-based whole-tumour-cell vaccine in mice bearing squamous cell carcinoma SCCVII.
    Marczynska J; Banas M; Guzik K; Koltun M; Majewski P; Cichy J; Krzykawska-Serda M; Makarska A; Kwitniewski M
    J Photochem Photobiol B; 2015 Dec; 153():455-62. PubMed ID: 26569454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.
    Shang D; Liu Y; Xu X; Han T; Tian Y
    Cancer Lett; 2011 Dec; 311(2):230-6. PubMed ID: 21880414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.
    Hagiwara H; Sato H; Ohde Y; Takano Y; Seki T; Ariga T; Hokaiwado N; Asamoto M; Shirai T; Nagashima Y; Yano T
    Br J Pharmacol; 2008 Apr; 153(7):1373-81. PubMed ID: 18264126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
    Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
    Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
    Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF
    Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.
    Li B; Zhu X; Sun L; Yuan L; Zhang J; Li H; Ye Z
    Oncotarget; 2014 Nov; 5(21):10791-802. PubMed ID: 25301731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?
    Neumann E; Engelsberg A; Decker J; Störkel S; Jaeger E; Huber C; Seliger B
    Cancer Res; 1998 Sep; 58(18):4090-5. PubMed ID: 9751617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of 5-aza-2'-deoxycytidine on the amount of exosomes and secreted immuno-associated proteins by hepatoma cells].
    Sanrengaowa ; Wu Y; Xiao WH
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):495-9. PubMed ID: 19950695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
    Pulukuri SM; Rao JS
    Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model.
    Guo ZS; Hong JA; Irvine KR; Chen GA; Spiess PJ; Liu Y; Zeng G; Wunderlich JR; Nguyen DM; Restifo NP; Schrump DS
    Cancer Res; 2006 Jan; 66(2):1105-13. PubMed ID: 16424047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY
    Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-expression of p16 gene in the myeloma cell line U266 induced by synergy of sodium butyrate and 5-Aza-2'-deoxycytidine.
    Du HL; Ren LM; Chen H; Zhu Y; Qi Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):981-4. PubMed ID: 12433622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.
    Schrump DS; Fischette MR; Nguyen DM; Zhao M; Li X; Kunst TF; Hancox A; Hong JA; Chen GA; Pishchik V; Figg WD; Murgo AJ; Steinberg SM
    Clin Cancer Res; 2006 Oct; 12(19):5777-85. PubMed ID: 17020984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development.
    Gjerstorff MF; Kock K; Nielsen O; Ditzel HJ
    Hum Reprod; 2007 Apr; 22(4):953-60. PubMed ID: 17208940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.
    Akcakanat A; Kanda T; Tanabe T; Komukai S; Yajima K; Nakagawa S; Ohashi M; Hatakeyama K
    Int J Cancer; 2006 Jan; 118(1):123-8. PubMed ID: 16003736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.
    Maio M; Coral S; Sigalotti L; Elisei R; Romei C; Rossi G; Cortini E; Colizzi F; Fenzi G; Altomonte M; Pinchera A; Vitale M
    J Clin Endocrinol Metab; 2003 Feb; 88(2):748-54. PubMed ID: 12574209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells.
    Chu SH; Ma YB; Feng DF; Zhang H; Qiu JH; Zhu ZA
    Mol Med Rep; 2012 Jan; 5(1):138-41. PubMed ID: 21993522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.